$NVAX it is going up and so are the rest of their competitors. this is a good week for biotech. but don’t expect it to be back ATH. maybe a boost around 130-150 on a good run and sideways action til it gets an approval. maybe another boost as it nears approval date. non-approval and negative side effect along the way, and you know how it goes.
  • 2